Colostrum Market Size & Share Growth Forecast Report (2026-2035)

Colostrum Market Overview

The colostrum market was valued at approximately USD 3.51 billion in 2025 and is expected to reach around USD 3.75 billion in 2026, rising to approximately USD 5.23 billion by 2035, registering a 6.88% CAGR from 2026 to 2035.

Research Highlights

• Whole colostrum held 65.42% in 2025 supported by its broad nutritional and bioactive composition.
• Powder accounted for 69.60% in 2025 backed by longer shelf life and efficient transportation.
• Bovine colostrum held 90.85% in 2025 due to established dairy supply networks.
• Organic colostrum is projected to grow at 10.02% CAGR because of growing demand for premium and sustainably produced ingredients.
• North America accounted for 43.90% in 2025 owing to established supplement, sports-nutrition and dairy-processing infrastructure.

Growth drivers include growing consumer demand for immunity and digestion-supporting products, as well as the ingredient’s expanding application base, from dietary and functional food to baby food and personal-care products. The wealth of immunoglobulins, lactoferrin, growth factors and other nutrients in colostrum keeps making it a sought-after natural ingredient. At the same time, government agencies and scientific research facilities are promoting the product as an essential component of neonatal nutrition. According to the Food and Agriculture Organization, colostrum provides protein and disease resistance for young calves. As per the AGRIS database managed by the same organization, colostrum plays a vital role in the development of the immune system and intestinal epithelium.

Colostrum Market Dynamics

Market Trends

The market witnesses a tendency towards premium, organic, and minimally processed products and is focused on natural ingredients derived from colostrum for daily use. Moreover, a transition towards liquid and special formulations is also seen in the market. Liquid colostrum is expected to witness an increase attributed to the rising demand for less-processed products as well as advanced cold-chain technologies and processing capabilities.

Growth Drivers

Immunomodulatory products’ rising demand is a significant force compelling the growth of the market. Dietary supplements constitute the majority of the market share. The tendency among consumers toward immunity-boosting and sports nutrition products encourages manufacturers to invest in colostrum processing into capsules, dietary supplements, beverages, and other products. Moreover, the need for infant nutrition constitutes a consistent source of demand for colostrum. Being rich in immunoglobulins and various health-benefiting substances, colostrum is vital for young animals’ health. According to the Food and Agriculture Organization (FAO), colostrum is essential for newborn animals, providing them with antibodies and passive immunity. Thus, colostrum processing into various dairy products for human use is in great demand.

Market Restraints / Challenges

However, the market is greatly hindered by the availability of the product. Colostrum can only be obtained during the first few days after the animal’s birthing period, and only a small amount is available for processing since some is needed for the calf’s nutrition. Moreover, processing requires specific technologies to maintain the quality and contents of the product. A portion of colostrum is lost during the freeze-drying process, making it challenging for manufacturers to make sufficient supplies for the ever-growing market.

Market Opportunities

Nevertheless, the market offers significant opportunities, primarily in organic and special formulations, liquid, and sports nutrition products. Special formulations are projected to witness exponential growth as manufacturers invest in the development of nutritional products for sports nutrition, immunity support, personal care, and other purposes. Moreover, there is also an opportunity to see colostrum processed into various health-benefiting products beyond the dietary supplement and drug industry.

Global Colostrum Market Report Coverage

Colostrum Market Segmentation

By Type

In 2025 whole colostrum pulled in 65.42% of market revenue backed by a broad nutritional profile and it also keeps the naturally occurring proteins, immunoglobulins, growth factors and other bioactive compounds intact. Whole colostrum shows up a lot in dietary supplements and functional food formulations, where brands want a more or less full picture representation of the raw material.

Specialty colostrum is estimated to climb at around 8.85% CAGR up to 2035, the momentum being tied to formulation improvements. Sports nutrition, cosmetics and specialized wellness products are also driving demand for higher-value formulations, and that boosts the segment’s overall market expansion.

By Form

Powder accounted for 69.60% of market revenue in 2025 due to longer shelf life, comparatively practical transportation, and as it works well across capsules, tablets, sachets and functional foods. Spray-drying and freeze-drying tech also help companies make shelf-stable commercial ingredients while still keeping key bioactive components.

Liquid colostrum is projected to grow at roughly 8.76% CAGR through 2035, and it is expected to be the fastest-moving form. That’s largely linked to shoppers leaning toward minimally processed products, plus the whole freshness and potency belief.

By Source

Bovine colostrum represented 90.85% of market revenue in 2025, creating a strong lead. This is because it’s widely available via established dairy networks and there’s extensive commercial processing infrastructure. Also, bovine material delivers a strong base of immunoglobulins and is commonly blended into nutritional supplements, functional foods and sports nutrition products.

The caprine segment is projected to grow at about 4.62% CAGR through 2031, and that rate is expected to outpace overall market growth. Support comes from continued investment in collection, standardization and processing technologies.

By Nature

Conventional colostrum accounted for 75.80% of market revenue in 2025. This is supported by established dairy supply chains, broader availability, and comparatively lower production costs. Conventional manufacturing also benefits from more mature collection and processing systems, letting producers provide large volumes into mainstream supplement and functional-food markets.

Organic colostrum is projected to expand at around 10.02% CAGR through 2035, making it the fastest-growing nature category. The growth mirrors increasing demand for organically produced and minimally processed ingredients, especially among premium wellness consumers.

Regional Insights

North America

North America accounted for the largest share of the market in terms of value in 2025, with approximately 43.90%, which is mainly attributed to the region’s developed dietary-supplement consumption base, well-established sports-nutrition channels and the presence of key players engaged in special processing of Colostrum products. Moreover, the dietary-supplement regulatory environment, including FDA’s regulatory framework for dietary supplements, contributes to the availability of Colostrum products. Additionally, a well-developed cold chain is another key driver for colostrum products in North America.

Europe

Europe, with 32.36% share, is another significant region for colostrum production and consumption due to the strong presence of dairy-processing infrastructure and the demand for natural health-care ingredients, organic dairy products, and preventive healthcare. Colostrum is a natural product obtained from cows, which is high in health-benefiting ingredients. In addition, the dietary-supplement and sports-nutrition industries are well-established in the region, enabling the expansion of colostrum product sales through various distribution channels. In addition, colostrum is in demand in the infant nutrition product category.

Asia Pacific

Asia Pacific is the fastest-growing region for the market, projected to register the highest CAGR of 10.25% during the forecast period. This growth is primarily driven by the growing consumer demand for colostrum products in China, India, and Southeast Asian countries, as well as the growing middle class and urbanization across the region. In addition, the increasing use of e-commerce platforms facilitates the sale of dietary-supplement and organic health products, including colostrum. The overall development of the dairy and nutrition industries in the region contributes to the growing supply base of colostrum.

Rest of the World

The rest of the world plays an essential role in the market with 13.49% share due to the increasing demand for colostrum in South America, the Middle East, and Africa, driven by a growing awareness of the benefits of organic and natural products. In addition, dairy farms in these regions contribute to the supply of colostrum, while the growing retail and e-commerce channels enable the sale of colostrum products.

Competitive Landscape / Company Insights

The market is moderately competitive with specialized ingredient manufacturers and nutrition companies competing on the basis of quality, processing technologies, organic production, and geographic reach. Producers are increasingly prioritizing standardized levels of immunoglobulins, traceability of supply chains, and special formulations for sports nutrition, digestion support, infant care, and other applications. Governmental and institutional authorities are actively involved in ensuring the quality and proper use of the product; for example, the FDA released a warning in 2026 about unauthorized therapeutic use of colostrum and related products, restricting the promotion of the substance’s unproven health benefits.

Mini Profiles

Agati Healthcare Pvt. Ltd. focuses on bovine and buffalo colostrum powders and specialized formulations, supported by differentiated IgG concentrations, granulated products and nutraceutical manufacturing capabilities.

Biostrum Nutraceutical LLP specializes in bovine colostrum powders, capsules and tablets, supported by GMP, ISO 22000, HALAL and organic certifications and established production capabilities.

Colostrum BioTec GmbH focuses on specialized bovine colostrum ingredients and nutritional products, supported by European processing expertise and applications across health and wellness formulations.

Deep Blue Health NZ develops New Zealand-sourced colostrum supplements, emphasizing pasture-raised dairy sourcing, immunoglobulin-rich formulations and quality-controlled manufacturing.

Glanbia plc develops dairy bioactive ingredients and nutrition solutions, supported by global formulation capabilities and growing commercial interest in colostrum for gut, immune and family nutrition.

Key Players

• Agati Healthcare Pvt. Ltd.
• Biostrum Nutraceutical LLP
• Colostrum BioTec GmbH
• Deep Blue Health NZ
• Glanbia plc
• Ingredia
• Nutritional
• NOW Health Group, Inc.
• PanTheryx , Inc.
• The Saskatoon Colostrum Company Ltd.
• SwissBioColostrum AG

Recent Developments

New Image Group appointed Scott Sherriff as Managing Director, supporting the company's next phase of international expansion while founder Graeme Clegg shifted greater attention toward research into colostrum's health benefits.

Ingredia Nutritional presented its Prodiet Colostrum ingredient at Global Pet Expo in the United States, highlighting its use in pet-health nutrition alongside other bioactive ingredients.

Deep Blue Health expanded its colostrum portfolio with capra-based formulations aimed at Asian e-commerce wellness markets, reflecting increasing diversification beyond conventional bovine products.

Glanbia plc reported continued demand for colostrum bioactives within its Dairy Nutrition business, particularly for gut-health and immunity applications. The company subsequently highlighted broader family-nutrition opportunities for colostrum in June 2026.

New Image Health Science Korea held its market-entry kickoff in Seoul, strengthening the company's presence in South Korea and highlighting colostrum-focused health and wellness products within its regional expansion strategy.

Table of Contents for Colostrum Market Report

1.    Research Overview

        1.1.    The Report Offers
        1.2.    Market Coverage
                  1.2.1.    By Type 
                  1.2.2.    By Form 
                  1.2.3.    By Source 
                  1.2.4.    By Nature 
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Market Methodology
                  1.5.1.  Data Sources
                             1.5.1.1. Primary Research
                             1.5.1.2. Secondary Research
                  1.5.2.  Methodology
                             1.5.2.1. Data Exploration
                             1.5.2.2. Forecast Parameters
                             1.5.2.3. Data Validation
                             1.5.2.4. Assumptions
                  1.5.3.  Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

       3.1.    Industry Dynamics
                 3.1.1.    Market Growth Drivers
                 3.1.2.    Market Restraints
                 3.1.3.    Key Market Trends
                 3.1.4.    Major Opportunities
       3.2.    Industry Ecosystem
                 3.2.1.    Porter’s Five Forces Analysis
                 3.2.2.    Recent Development Analysis
                 3.2.3.    Value Chain Analysis
       3.3.    Competitive Insight
                 3.3.1.    Competitive Position of Industry Players
                 3.3.2.    Market Attractive Analysis
                 3.3.3.    Market Share Analysis

4.    Global Market Estimate and Forecast

       4.1.    Global Market Overview
       4.2.    Global Market Estimate and Forecast to 2035

5.    Market Segmentation Estimate and Forecast

       5.1.    By Type 
                 5.1.1. Whole Colostrum
                           5.1.1.1. Market Definition
                           5.1.1.2. Market Estimation and Forecast to 2035
                 5.1.2. Skimmed Colostrum
                           5.1.2.1. Market Definition
                           5.1.2.2. Market Estimation and Forecast to 2035
                 5.1.3. Specialty Colostrum
                           5.1.3.1. Market Definition
                           5.1.3.2. Market Estimation and Forecast to 2035

       5.2.    By Form 
                 5.2.1. Powder
                           5.2.1.1. Market Definition
                           5.2.1.2. Market Estimation and Forecast to 2035
                 5.2.2. Chewable Tablets
                           5.2.2.1. Market Definition
                           5.2.2.2. Market Estimation and Forecast to 2035
                 5.2.3. Liquid
                           5.2.3.1. Market Definition
                           5.2.3.2. Market Estimation and Forecast to 2035
                 5.2.4. Others
                           5.2.4.1. Market Definition
                           5.2.4.2. Market Estimation and Forecast to 2035

       5.3.    By Source 
                 5.3.1. Bovine
                           5.3.1.1. Market Definition
                           5.3.1.2. Market Estimation and Forecast to 2035
                 5.3.2. Caprine
                           5.3.2.1. Market Definition
                           5.3.2.2. Market Estimation and Forecast to 2035
                 5.3.3. Others
                           5.3.3.1. Market Definition
                           5.3.3.2. Market Estimation and Forecast to 2035

       5.4.    By Nature 
                 5.4.1. Conventional
                           5.4.1.1. Market Definition
                           5.4.1.2. Market Estimation and Forecast to 2035
                 5.4.2. Organic
                           5.4.2.1. Market Definition
                           5.4.2.2. Market Estimation and Forecast to 2035

6.   North America Market Estimate and Forecast

      6.1.    By Type   
      6.2.    By Form   
      6.3.    By Source   
      6.4.    By Nature   
                6.4.1.     U.S. Market Estimate and Forecast
                6.4.2.     Canada Market Estimate and Forecast
                6.4.3.     Mexico Market Estimate and Forecast

7.   Europe Market Estimate and Forecast

      7.1.    By Type   
      7.2.    By Form   
      7.3.    By Source   
      7.4.    By Nature   
                7.4.1.     Germany Market Estimate and Forecast
                7.4.2.     France Market Estimate and Forecast
                7.4.3.     U.K. Market Estimate and Forecast
                7.4.4.     Italy Market Estimate and Forecast
                7.4.5.     Spain Market Estimate and Forecast
                7.4.6.     Russia Market Estimate and Forecast
                7.4.7.     Rest of Europe Market Estimate and Forecast

8.   Asia-Pacific (APAC) Market Estimate and Forecast

      8.1.    By Type   
      8.2.    By Form   
      8.3.    By Source   
      8.4.    By Nature   
                8.4.1.     China Market Estimate and Forecast
                8.4.2.     Japan Market Estimate and Forecast
                8.4.3.     India Market Estimate and Forecast
                8.4.4.     South Korea Market Estimate and Forecast
                8.4.5.     Rest of Asia-Pacific Market Estimate and Forecast

9.   Rest of the World (RoW) Market Estimate and Forecast

      9.1.    By Type   
      9.2.    By Form   
      9.3.    By Source   
      9.4.    By Nature   
                9.4.1.     Brazil Market Estimate and Forecast
                9.4.2.     Saudi Arabia Market Estimate and Forecast
                9.4.3.     South Africa Market Estimate and Forecast
                9.4.4.     U.A.E. Market Estimate and Forecast
                9.4.5.     Other Countries Market Estimate and Forecast

10.  Company Profiles

       10.1.   Agati Healthcare Pvt. Ltd.
                  10.1.1.    Snapshot
                  10.1.2.    Overview
                  10.1.3.    Offerings
                  10.1.4.    Financial Insight
                  10.1.5.    Recent Developments
       10.2.   Biostrum Nutraceutical LLP
                  10.2.1.    Snapshot
                  10.2.2.    Overview
                  10.2.3.    Offerings
                  10.2.4.    Financial Insight
                  10.2.5.    Recent Developments
       10.3.   Colostrum BioTec GmbH
                  10.3.1.    Snapshot
                  10.3.2.    Overview
                  10.3.3.    Offerings
                  10.3.4.    Financial Insight
                  10.3.5.    Recent Developments
       10.4.   Deep Blue Health NZ
                  10.4.1.    Snapshot
                  10.4.2.    Overview
                  10.4.3.    Offerings
                  10.4.4.    Financial Insight
                  10.4.5.    Recent Developments
       10.5.   Glanbia plc
                  10.5.1.    Snapshot
                  10.5.2.    Overview
                  10.5.3.    Offerings
                  10.5.4.    Financial Insight
                  10.5.5.    Recent Developments
       10.6.   Ingredia Nutritional
                  10.6.1.    Snapshot
                  10.6.2.    Overview
                  10.6.3.    Offerings
                  10.6.4.    Financial Insight
                  10.6.5.    Recent Developments
       10.7.   NOW Health Group, Inc.
                  10.7.1.    Snapshot
                  10.7.2.    Overview
                  10.7.3.    Offerings
                  10.7.4.    Financial Insight
                  10.7.5.    Recent Developments
       10.8.   PanTheryx, Inc.
                  10.8.1.    Snapshot
                  10.8.2.    Overview
                  10.8.3.    Offerings
                  10.8.4.    Financial Insight
                  10.8.5.    Recent Developments
       10.9.   The Saskatoon Colostrum Company Ltd.
                  10.9.1.    Snapshot
                  10.9.2.    Overview
                  10.9.3.    Offerings
                  10.9.4.    Financial Insight
                  10.9.5.    Recent Developments
       10.10.   SwissBioColostrum AG
                  10.10.1.    Snapshot
                  10.10.2.    Overview
                  10.10.3.    Offerings
                  10.10.4.    Financial Insight
                  10.10.5.    Recent Developments

11.    Appendix

         11.1.    Exchange Rates
         11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.